Revolutionizing Southeast Asia’s Research Landscape: BioSkryb Genomics Joins Forces with Research Instruments Pte Ltd to Introduce Cutting-Edge Single-Cell Technologies to Singapore and Beyond!

Unleashing the Future of Research: BioSkryb Genomics and Everlife-RI Join Forces to Illuminate Southeast Asia with Cutting-Edge Single-Cell Multiomics Solutions

DURHAM, N.C.–(BUSINESS WIRE)– In a groundbreaking move set to redefine the scientific landscape, BioSkryb Genomics has ignited a dynamic partnership with Everlife-Research Instruments (Everlife-RI). This collaboration brings BioSkryb’s revolutionary ResolveDNA® and game-changing ResolveOME™ single-cell amplification tools to Singapore and Southeast Asia, breaking barriers in single-cell analysis. Everlife-RI, a trailblazer in life science research product distribution, is poised to empower researchers across the region with these transformational technologies.

BioSkryb’s ResolveDNA technology unveils the secrets of whole genomes and exomes within individual cells, unveiling the mysteries of diseases at their core. Traditional amplification techniques fall short, often plagued by biases and reproducibility issues. Enter ResolveDNA, a champion of unbiased, high-resolution insights.

And that’s not all—meet ResolveOME, a true marvel of multiomics. Imagine deciphering the entire genome and transcriptome of individual cells, seamlessly integrating the complex dance of genes and molecules. With BioSkryb’s patented primary template-directed amplification (PTA) technology, ResolveOME achieves an unprecedented 97% genomic coverage. This groundbreaking power, combined with BioSkryb’s BaseJumper™ bioinformatics platform, opens the doors to a new era of understanding complex diseases at the cellular level.

Suresh Pisharody, the visionary CEO of BioSkryb Genomics, exclaimed, ‘Our journey with Everlife-RI marks a pivotal moment. Together, we will unravel the intricacies of diseases and drive transformative advancements in research, diagnostics, and treatments across Southeast Asia.’

Yeo Seok Hoon, the forward-looking CEO of Everlife-Research Instruments, echoed the sentiment, ‘Empowerment through innovation is our ethos. BioSkryb’s tools offer an unprecedented glimpse into single-cell complexities. We are excited to amplify access to these game-changing solutions throughout Southeast Asia.’

Everlife-RI, the vanguard distributor of genomic and life science research products, possesses a seasoned technical force and established customer relationships, poised to revolutionize research landscapes.

About BioSkryb Genomics

BioSkryb Genomics is a trailblazing organization, revolutionizing single-cell molecular exploration. Unveiling the genome, transcriptome, and proteome within individual cells, their single-cell amplification tools redefine our understanding of complex diseases. The hub of innovation lies in Durham, North Carolina, driving the future of cellular insights.

About Everlife-Research Instruments

For generations, Everlife-Research Instruments has been the guiding light for Southeast Asia’s scientific pioneers. From our vibrant headquarters in Singapore, we’ve rallied unwavering sales, marketing, and support squads – all on a mission to Ignite Progress for the region’s life sciences community. Armed with top-tier tools and backed by world-class expertise, we’re not just redefining quality; we’re sculpting outcomes. As a proud member of the Everlife Group, a juggernaut in Asia’s market landscape, we’re not just shaping the future – we’re living it.

Leave a Comment